Végh Á - Search Results

1

ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy.

Nagy L, Pollesello P, Haikala H, Végh Á, Sorsa T, Levijoki J, Szilágyi S, Édes I, Tóth A, Papp Z, Papp JG. Nagy L, et al. Among authors: vegh a. Eur J Pharmacol. 2016 Mar 15;775:120-9. doi: 10.1016/j.ejphar.2016.02.028. Epub 2016 Feb 9. Eur J Pharmacol. 2016. PMID: 26872993

2

Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs.

Papp JG, Pollesello P, Varró AF, Végh AS. Papp JG, et al. J Cardiovasc Pharmacol Ther. 2006 Jun;11(2):129-35. doi: 10.1177/1074248406289286. J Cardiovasc Pharmacol Ther. 2006. PMID: 16891290

3

The effect of levosimendan during long-term amiodarone treatment in dogs.

Papp JG, Pollesello P, Varró A, Végh A, Udvary E. Papp JG, et al. Among authors: vegh a. Basic Clin Pharmacol Toxicol. 2006 Jul;99(1):27-32. doi: 10.1111/j.1742-7843.2006.pto_394.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16867167 Free article.

4

Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.

Vegh A, Papp JG, Parratt J. Vegh A, et al. Br J Pharmacol. 1994 Dec;113(4):1167-72. doi: 10.1111/j.1476-5381.1994.tb17120.x. Br J Pharmacol. 1994. PMID: 7534181 Free PMC article.

5

Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.

Udvary E, Papp JG, Végh A. Udvary E, et al. Among authors: vegh a. Br J Pharmacol. 1995 Feb;114(3):656-61. doi: 10.1111/j.1476-5381.1995.tb17189.x. Br J Pharmacol. 1995. PMID: 7735692 Free PMC article.

6

Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing.

Vegh A, Papp JG, Parratt JR. Vegh A, et al. Br J Pharmacol. 1994 Dec;113(4):1081-2. doi: 10.1111/j.1476-5381.1994.tb17104.x. Br J Pharmacol. 1994. PMID: 7889255 Free PMC article.

7

Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.

Vegh A, Györgyi K, Papp JG, Sakai K, Parratt JR. Vegh A, et al. Eur J Pharmacol. 1996 Jun 3;305(1-3):163-8. doi: 10.1016/0014-2999(96)00166-5. Eur J Pharmacol. 1996. PMID: 8813547

8

Hemodynamic effects of calcium-sensitizing agents.

Vegh A, Papp JG, Udvary E, Kaszala K. Vegh A, et al. J Cardiovasc Pharmacol. 1995;26 Suppl 1:S20-31. J Cardiovasc Pharmacol. 1995. PMID: 8907128 Review.

9

Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias.

Kaszala K, Végh A, Papp JG, Parratt JR. Kaszala K, et al. Among authors: vegh a. Eur J Pharmacol. 1997 Jun 5;328(1):51-60. doi: 10.1016/s0014-2999(97)83027-0. Eur J Pharmacol. 1997. PMID: 9203568

10

Does the opening of ATP-sensitive K+ channels modify ischaemia-induced ventricular arrhythmias in anaesthetised dogs?

Vegh A, Papp JG, György K, Kaszala K, Parratt JR. Vegh A, et al. Eur J Pharmacol. 1997 Aug 20;333(1):33-8. doi: 10.1016/s0014-2999(97)01088-1. Eur J Pharmacol. 1997. PMID: 9311658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters